Document Detail

Novel serum paraoxonase activity assays are associated with coronary artery disease.
MedLine Citation:
PMID:  19275503     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Serum paraoxonase (PON1) exerts antiatherogenic effects. Novel PON1 enzymatic tests have been recently developed: 5-thiobutyl butyrolactone (TBBL) estimates PON1 lactonase activity, whereas 7-O-diethylphosphoryl-3-cyano-4-methyl-7-hydroxycoumarin (DEPCyMC) is considered a surrogate marker of PON1 concentration. The TBBL to DEPCyMC ratio provides the normalized lactonase activity (NLA), which may reflect the degree of PON1 lactonase catalytic stimulation. The aim of this study was to evaluate for the first time TBBLase and DEPCyMCase activity in patients with coronary artery disease (CAD). METHODS: An angiography-based case-control study was conducted, including 300 sex- and age-matched subjects [100 CAD-free, 100 CAD without myocardial infarction (MI) and 100 CAD with MI]. RESULTS: A low DEPCyMCase activity (lowest vs. highest tertile: OR 2.96, 95% CI 1.18-7.43) and a high NLA (highest vs. lowest tertile: OR 3.25, 95% CI 1.28-8.26) were both associated with CAD, independent of classical atherosclerosis risk factors, lipid-lowering therapy and PON1 genotype. Total TBBLase activity was, however, not different in CAD compared to CAD-free subjects. CONCLUSIONS: Novel PON1 activity assays may be associated with CAD. In this study, CAD patients had low DEPCyMCase activity, a possible marker of low PON1 concentration, but showed a high stimulation of PON1 lactonase activity.
Nicola Martinelli; Domenico Girelli; Oliviero Olivieri; Patrizia Guarini; Antonella Bassi; Elisabetta Trabetti; Simonetta Friso; Francesca Pizzolo; Claudia Bozzini; Ilaria Tenuti; Laura Annarumma; Renzo Schiavon; Pier Franco Pignatti; Roberto Corrocher
Related Documents :
18762553 - Combined coronary and late-enhanced multidetector-computed tomography for delineation o...
8900333 - Risk stratification in coronary artery disease and special populations.
8586833 - Combined effects of blood pressure and body mass index on left ventricular structure in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical chemistry and laboratory medicine : CCLM / FESCC     Volume:  47     ISSN:  1434-6621     ISO Abbreviation:  Clin. Chem. Lab. Med.     Publication Date:  2009  
Date Detail:
Created Date:  2009-03-30     Completed Date:  2009-06-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9806306     Medline TA:  Clin Chem Lab Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  432-40     Citation Subset:  IM    
Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aryldialkylphosphatase / metabolism*
Coronary Artery Disease / blood*,  diagnosis,  enzymology*
Immunoassay / methods*
Middle Aged
Risk Factors
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A high-performance liquid chromatography method for the determination of carbamazepine and carbamaze...
Next Document:  New approved dasatinib regimen available for clinical use.